SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
A study published in Oncogene has demonstrated the role of S-phase protein kinase 2 (Skp2) in the progression of castration-resistant prostate cancer (CRPC) via Twist-mediated functions including ...
Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of life, not just disease control. The Quality-Adjusted Time without Symptoms or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback